Premium
Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
Author(s) -
Kitzmüller Claudia,
JahnSchmid Beatrice,
Kinaciyan Tamar,
Bohle Barbara
Publication year - 2019
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.13779
Subject(s) - allergen , slit , allergy , medicine , immunology , immunoglobulin e , placebo , food allergy , desensitization (medicine) , sensitization , immunotherapy , oral allergy syndrome , pollen , concomitant , sublingual administration , recombinant dna , antibody , biology , immune system , botany , pathology , receptor , biochemistry , gene , genetics , alternative medicine
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom